Cirius Therapeutics Files For IPO
JANUARY 14, 2019
San Diego-based Cirius Therapeutics , a venture-backed biotech startup developing treatments for liver disease, has filed for an IPO, saying it is looking to raise up to $86.25M in funding on the Nasdaq Global Select Market as CSTX. The company's IPO is being underwritten by Citigroup, Credit Suisse, Needham & Company, and Wedbush PacGrow. The startup--led by Robert Baltura, Jr.--is is venture backed by Frazier Life Sciences, Novo Holdings A/S, Adams Street Partners, and the William D.